Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Chief Product Officer | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,009 |
Reported balance
After 2026-09-17 transaction · row 1
1 source rowRow 1 · 2026-09-17 · Tax withholding · Disposed 819 · Balance 59,009 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 21, 2026 21:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 819 | $27.38 | $22,424.22 |
DisclosureSEC source: 0001551306-26-000156 · wk-form4_1790025656.xml · nonDerivative · entry 1 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,009 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| June 17, 2026 Filed Jun 23, 2026 20:07 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 819 | $26.60 | $21,785.40 |
DisclosureSEC source: 0001551306-26-000129 · wk-form4_1782245242.xml · nonDerivative · entry 1 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,828 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:52 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,909 | $0.00 Strike: $20.91 | $0.00 |
DisclosureSEC source: 0001551306-26-000117 · wk-form4_1780519918.xml · derivative · entry 4 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,211 Underlying: Common Stock · 12,909 shares Expires 2035-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 33% of the shares will vest on March 17, 2026, with the remainder vesting quarterly in equal installments thereafter through March 17, 2028, subject to the Reporting Person's continued service on each applicable vesting date. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:52 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 11,379 | $25.54 | $290,619.66 |
DisclosureSEC source: 0001551306-26-000117 · wk-form4_1780519918.xml · nonDerivative · entry 3 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,647 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:52 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 12,909 | $20.91 | $269,927.19 |
DisclosureSEC source: 0001551306-26-000117 · wk-form4_1780519918.xml · nonDerivative · entry 2 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:52 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,530 | $25.58 | $39,137.40 |
DisclosureSEC source: 0001551306-26-000117 · wk-form4_1780519918.xml · nonDerivative · entry 1 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,117 Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 3,275 | $17.42 | $57,050.50 |
DisclosureSEC source: 0001551306-26-000042 · wk-form4_1773954773.xml · nonDerivative · entry 1 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,647 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 51,373 | $0.00 Strike: $17.60 | $0.00 |
DisclosureSEC source: 0001551306-26-000033 · wk-form4_1772663555.xml · derivative · entry 2 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,373 Underlying: Common Stock · 51,373 shares Expires 2036-03-01 F2 · derivative.exercise_date: Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 33% of the shares will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 35,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-26-000033 · wk-form4_1772663555.xml · nonDerivative · entry 1 Clapp Geoffrey · CIK 0002065409 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,922 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.